Lupin launches inhalation device in US

19 Feb 2015 Evaluate

Lupin has unveiled an inhalation-drug delivery device InspiraChamber in licensing pact with New Jersey-based respiratory research and development company InspiRX Inc. Developed by InspiRX, the InspiraChamber anti-static valved holding chamber is a device that has been designed to enhance delivery of aerosol therapies. The agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber in the US.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.

 

Lupin Share Price

1615.85 20.95 (1.31%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.